Sign In
Buy ABBV
$217.07
+1.64 (+0.761%)
At Close: Jun 03, 2026
Market Today: Tech Slumps, Broadcom Tanks; EU Eases ICE Ban
05:35pm, Friday, 12'th Dec 2025
Stock News Tech-led selloff caps tough week: US stocks fell as investors rotated out of mega-cap tech after Broadcom (AVGO) and Oracle (ORCL) stoked AI-spending
Here Are 2 Affordable Healthcare Stocks to Buy Heading Into 2026
12:23pm, Friday, 12'th Dec 2025
One of these pharmaceutical leaders overcame a major obstacle and has a strong outlook. The other is actively pushing greater innovation to get around a rapidly approaching patent cliff.
AbbVie Slipped Below 50-Day SMA Last Week: How to Play the Stock
08:46am, Friday, 12'th Dec 2025
AbbVie dips below its 50-day SMA, but strong immunology momentum and a resilient long-term trend keep the story compelling.
First Look: Lululemon shake-up, Broadcom AI jitters, Costco beat
07:38am, Friday, 12'th Dec 2025
Stock News Lululemon leadership change lifts shares: Lululemon Athletica (LULU) said CEO Calvin McDonald will step down Jan. 31, with CFO Meghan Frank and CCO A
Proven Income Generators: Ranking the Most Reliable Dividend Growth Stocks
07:22am, Friday, 12'th Dec 2025
Dividend investing rewards patience. The best dividend stocks don't just pay consistently—they raise payouts year after year, compounding income for shareholders who stay the course.
Dividend Powerhouses: 3 Blue-Chip Stocks Built for the Long Haul
07:07am, Friday, 12'th Dec 2025
The wall of worry continues to grow as investors race into 2026. Concentration risk is one that may not get talked about enough.
The Smartest Dividend Stocks to Buy With $5,000 Right Now
04:00am, Friday, 12'th Dec 2025
Bank of America's low payout ratio means this is a dividend you can count on. AbbVie's raking in money with immunology drugs Skyrizi and Rinvoq.
Market Today: Fed Cut, Oracle Slide, Broadcom AI Surge
05:35pm, Thursday, 11'th Dec 2025
Stock News Oracle sinks, ripples across AI trade: Oracle (ORCL) fell about 11% after a revenue miss and heavier AI capex drove negative free cash flow, pressuri
Is AbbVie Stock Too Cheap to Ignore at Today's Price?
11:06am, Thursday, 11'th Dec 2025
Some valuation metrics suggest that AbbVie is a cheap stock. The company's growth prospects through 2030 look attractive.
Here's How AbbVie's Oncology Drugs are Aiding Top-line Growth
08:51am, Thursday, 11'th Dec 2025
ABBV's expanding oncology lineup, spanning new solid tumor drugs and rising Venclexta sales, is helping drive steady top-line growth.
First Look: Fed Cut, Oracle Miss, AI/Media M&A
07:38am, Thursday, 11'th Dec 2025
Stock News Fed delivers third 2025 cut: The Federal Reserve lowered the funds rate by 25 bps to 3.50%-3.75% in a split vote, signaled just one cut in 2026, and
AbbVie: Unique Mix Of Growth And Value
08:01pm, Wednesday, 10'th Dec 2025
AbbVie earns a Strong Buy rating, driven by exceptional execution post-Humira patent cliff and robust 2025 share price outperformance. Skyrizi and Rinvoq are rapidly replacing Humira, delivering 47% a
This Dividend Pharma Giant Yielding 2.9% Just Got a Big Vote of Confidence
12:19pm, Wednesday, 10'th Dec 2025
Healthcare stocks have lagged the broader market for the past three years, weighed down by post-COVID earnings volatility, policy uncertainties around drug pricing, and a surge in tech-driven gains fr
Pre-Market Stock Futures: Futures are trading modestly lower as the big day has finally arrived: the Federal Reserve will wrap up its last meeting of 2025, and the odds still heavily favor a 25-basis-
Market Today: Fed Cut Looms, Nvidia's China Shift, Target's SoHo Push, OpenAI Taps Slack CEO
05:34pm, Tuesday, 09'th Dec 2025
Stock News Fed set for âhawkish cut': Goldman Sachs (GS) and other Wall Street desks expect the Federal Reserve to deliver a third straight 25 bps rate cut wh
